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Abstract 17 
 18 
Endometrial stem-like cells, including mesenchymal stem cells (MSCs) and epithelial 19 
progenitor cells, are essential for cyclic regeneration of the endometrium following menstrual 20 
shedding. Emerging evidence indicates that endometrial MSCs (eMSCs) constitute a dynamic 21 
population of cells that enables the endometrium to adapt in response to a failed pregnancy. 22 
Recurrent miscarriage is associated with relative depletion of endometrial eMSCs, which not 23 
only curtails the intrinsic ability of the endometrium to adapt to reproductive failure but also 24 
compromises endometrial decidualization, an obligatory transformation process for embryo 25 
implantation. These novel findings should pave the way for more effective screening of 26 
women at risk of pregnancy failure prior to conception.  27 
 28 
 29 
 30 
  31 
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Introduction 32 
 33 
Successful implantation of a human embryo is commonly attributed to binary variables; i.e. 34 
nidation of a ‘normal’ but not ‘abnormal’ embryo in a ‘receptive’ but not a ‘non-receptive’ 35 
endometrium is required for a successful pregnancy.  However, this implantation paradigm is 36 
based on animal studies, more specifically the mouse model (Wang and Dey, 2006). Like 37 
many other rodents, mouse reproductive success is based on quantity: characterized by rapid 38 
breeding cycles, multiple synchronous implantations, large litter size, and, crucially, huge 39 
natural selection among offspring (Taylor, 2016). Mouse offspring “quality” is arrived at 40 
mainly through sibling rivalry after birth. By contrast, human pregnancy requires prolonged 41 
investment in a single fetus at considerable cost to the mother (Haig, 1993). Maternal cost, 42 
and the risk of neonatal death, increases sharply with each additional fetus (e.g. twins, triplets 43 
etc.) (Refuerzo, 2012). From an evolutionary perspective, a reproductive strategy based on 44 
prolonged maternal investment in singleton pregnancies makes sense only if based on an 45 
intrinsically dynamic and adaptable implantation process (Macklon and Brosens, 2014).  46 
 47 
And it is. Cleavage-stage human embryos both tolerate and actively generate aneuploid 48 
blastomeres through mitotic non-disjunction. As a consequence, most human embryos are 49 
mosaic (Vanneste et al., 2009, Taylor et al., 2014). With over 2,500 distinct genetic errors 50 
documented to date (Fragouli et al., 2013), each implanting blastocyst is arguably unique. 51 
Furthermore, transient aneuploidy during development may not be unequivocally as ‘bad’ as 52 
has been intuitively presumed because of the obvious link with cancer and congenital 53 
abnormalities. Emerging evidence suggests that aneuploidy drives rapid phenotypic 54 
adaptation (Kaya et al., 2015, Liu et al., 2015, Millet et al., 2015), confers resistance to 55 
cellular stress (Chen et al., 2012, Duncan et al., 2012, Kaya et al., 2015), and arguably 56 
imparts invasiveness on embryos necessary for implantation and deep placentation. Recent 57 
reports demonstrated unequivocally that embryos harboring complex mosaic aneuploidies 58 
can give rise to healthy offspring, both in humans and, experimentally, in mice (Bolton et al., 59 
2016, Greco et al., 2015). 60 
 61 
Several mechanisms ensure survival of mosaic embryos, including self-correction through 62 
apoptosis and possibly sequestration of aneuploid cells into the trophoblast lineage (Bolton et 63 
al., 2016) (Figure 1). However, invasiveness combined with the exceptional diversity of 64 
human embryos necessitates the need for additional, external (i.e. uterine) selection to limit 65 
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the risk of maternal investment in a failing pregnancy (Gellersen and Brosens, 2014, Macklon 66 
and Brosens, 2014). The first evidence that the endometrium is an intrinsic biosensor of 67 
embryo quality actually originated from studies in cattle. Microarray studies showed that the 68 
pregnant bovine endometrium mounts a transcriptional response that is distinct for embryos 69 
generated by artificial insemination, IVF, or somatic cell nuclear transfer (Mansouri-Attia et 70 
al., 2009). Decidualizing human endometrial stromal cells have since emerged as exquisite 71 
sensors that respond to as yet unidentified embryonic serine proteases in a manner that either 72 
supports further development (positive selection) or ensures rapid disposal through 73 
menstruation-like shedding (negative selection) (Brosens et al., 2014b). Quality control may 74 
not necessarily cease once the conceptus is embedded in the endometrium but likely 75 
continues throughout the first trimester of pregnancy. For example, the gradual shift from 76 
ovarian to placental progesterone production arguably means that the endometrium will de 77 
facto select against embryos that are perceived to lack fitness because of insufficient human 78 
chorionic gonadotropin production. Similarly, the onset of placental perfusion around week 79 
10 of pregnancy causes dramatic changes in local oxygen tension and triggers bursts of free 80 
radicals (Burton et al., 1999) (Figure 1), effectively stress-testing the feto-maternal interface. 81 
Thus, suboptimal selection at implantation inevitably increases the risk of clinical 82 
miscarriage; and conversely, once all selection pressures have been endured successfully by 83 
the end of the 1
st
 trimester, the likelihood of further catastrophic failure drops markedly 84 
(Figure 1). The corollary of inefficient embryo selection at implantation is rapid conception, 85 
defined by short time-to pregnancy interval. It has been estimated that 40% of recurrent 86 
miscarriage patients are superfertile, defined by the fact that each pregnancy is achieved 87 
within 3 cycles (Orlando and Coulam, 2014, Teklenburg et al., 2010, Salker et al., 2010).  88 
 89 
Endometrial stem cells are perhaps the least appreciated and least understood drivers of 90 
reproductive plasticity. Considering the unrivalled regenerative capacity of the endometrium, 91 
it is remarkable, if not baffling, that the first experimental study demonstrating the presence 92 
of resident endometrial mesenchymal stem cells (eMSCs) was reported only 12 years ago 93 
(Chan et al., 2004). eMSCs are abundant, multipotent, immuno-privileged, and highly 94 
regenerative in various pre-clinical models of disease (reviewed in Mutlu et al., 2015).  95 
 96 
In this commentary, we explore the role of endometrial MSCs in effecting one of the most 97 
salient aspects of human reproduction, i.e. the ability to achieve a live birth after multiple 98 
pregnancy failures.  99 
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 100 
Persistent reproductive failure 101 
 102 
One of the most disappointing aspects of modern reproductive medicine is the pervasive 103 
puerile view of implantation and early pregnancy. Patients suffering from reproductive 104 
failure, i.e. repeated IVF implantation failures or recurrent miscarriage, continue to be 105 
subjected to a battery of screening tests for subclinical ‘disorders’, which are presumed to 106 
converge somehow onto a ‘fragile’ implanting embryo, causing reproductive failure. 107 
Numerous anatomical, endocrine, immunological, thrombophilic and genetic perturbations 108 
have been invoked to explain persistent reproductive failure (Agenor and Bhattacharya, 2015, 109 
Rai and Regan, 2006). Yet every diagnostic test currently in clinical practice lacks specificity, 110 
meaning that many women with normal pregnancies also test positive. Nevertheless, it 111 
remains standard practice to label a ‘positive’ test as ‘causal’, ignoring the lack of clinical 112 
evidence, biological plausibility, or the absence of interventions that are even remotely 113 
effective. In the absence of a ‘positive’ test, many clinicians resort to exalting the virtues of 114 
vitamins, micronutrients and other soft interventions. Others advocate an interventional 115 
approach, using a range of combinatory empirical treatments (e.g. heparin, aspirin, steroids, 116 
human chorionic gonadotropin, intravenous immunoglobulin, hydroxychloroquine, 117 
intralipids, TNFα inhibitors, etc.) as well as pre-implantation genetic screening of IVF 118 
embryos. None of these interventions have been conclusively shown to improve reproductive 119 
success; and some may well be harmful.  120 
 121 
And yet, despite this lamentable state of affairs, most women suffering either repeated 122 
implantation failure or recurrent miscarriage do achieve a successful pregnancy (Saravelos 123 
and Regan, 2014, Brigham et al., 1999, Ogasawara et al., 2000, Practice Committee of the 124 
American Society for Reproductive, 2012, Vlaanderen, 2014), irrespective of treatment. For 125 
example, several randomized control trials on recurrent miscarriage, defined here as 3 126 
consecutive pregnancy losses, reported life-births rate of 65% or more in the placebo group 127 
(Coomarasamy et al., 2015, Pasquier et al., 2015). In recurrent miscarriage, the incidence of 128 
euploid fetal loss increases with each additional miscarriage, whereas the likelihood of a 129 
future successful pregnancy gradually decreases (Ogasawara et al., 2000). These observations 130 
indicate that RM is a graded disorder with the level of severity defined by the number of 131 
previous pregnancy losses. Nevertheless, even after 5 consecutive miscarriages, the 132 
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likelihood of a life-birth in the subsequent pregnancy remains in excess of 50% (Rai and 133 
Regan, 2006, Brigham et al., 1999).  134 
 135 
A parsimonious explanation for these clinical observations is that embryo-endometrial 136 
interactions are intrinsically dynamic and capable of adapting from pregnancy to pregnancy 137 
to ensure reproductive success. The more severe the defect, however, the higher the 138 
likelihood of repeated pregnancy failures in consecutive conception cycles.  139 
 140 
The decidualizing endometrium in recurrent miscarriage 141 
 142 
Much of the work on the endometrium in the context of recurrent miscarriage has focused on 143 
decidualization, an obligatory transformative process for pregnancy in all mammalian species 144 
where implantation involves breaching of the luminal endometrial epithelium by the 145 
conceptus (Ramsey et al., 1976). The decidual process is foremost characterized by 146 
transformation of endometrial fibroblasts into specialized epithelioid cells. In parallel, the 147 
endometrium undergoes extensive remodeling, effected by the influx of specialized immune 148 
cells, predominantly uterine natural killer cells and macrophages (reviewed by Gellersen and 149 
Brosens, 2014). Associated vascular changes then prepare the human endometrium for 150 
endovascular trophoblast invasion and the formation of a functional haemochorial placenta 151 
(Brosens et al., 2002). Decidual cells encapsulate and safeguard the conceptus against various 152 
stressors. For example, stress-induced signaling through c-Jun N-terminal kinase and p38 153 
mitogen-activated protein kinase pathways is selectively inactivated upon decidualization of 154 
human endometrial stromal cells (Leitao et al., 2010, Yoshino et al., 2003, Leitao et al., 155 
2011). In parallel with a marked induction of various free radical scavengers, silencing of 156 
stress-signaling pathways renders decidual cells extraordinarily resistant to oxidative cell 157 
death (Kajihara et al., 2006). Moreover, circadian oscillations within the endometrium are 158 
firmly disabled upon decidualization (Muter et al., 2015), which further isolates the 159 
implanting blastocyst from the maternal environment. Decidual cells are also gatekeepers and 160 
chief modulators of local immune cells at the embryo-endometrial interface. In pregnancy, 161 
decidual cells also actively prevent influx of antigen-specific cytotoxic T lymphocytes by 162 
silencing of genes encoding key chemokines (Nancy et al., 2012).  163 
 164 
Importantly, decidualization is not an all or nothing phenomenon. Instead, differentiating 165 
human endometrial stromal cells transit through distinct functional phenotypes upon 166 
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transformation into decidual cells (Lucas et al., 2016, Salker et al., 2012). This transitional 167 
pathway, which can be recapitulated in culture, is characterized initially by an acute pro-168 
inflammatory response, lasting several days. Release by differentiating endometrial stromal 169 
cells of ‘alarmins’ like interleukin-33, a potent activator of the innate immune system, has 170 
emerged as an important driver of this transient inflammatory process (Salker et al., 2012). 171 
These inflammatory mediators in turn up-regulate the expression of key implantation genes, 172 
including leukemia inhibitory factor, interleukin 1-β, heparin binding EGF, bone 173 
morphogenetic protein 2, wingless-related MMTV integration site 4, and homeobox protein 174 
10. Acquisition of a mature decidual phenotype curtails the inflammatory response through 175 
induction of anti-inflammatory soluble decoy receptors (Salker et al., 2012) and pronounced 176 
upregulation of 11β-hydroxysteroid dehydrogenase type 1, leading to increased local cortisol 177 
production (Kuroda et al., 2013a, Kuroda et al., 2013b). Decidual factors such as LEFTY2 178 
contribute to the active closure of the window of receptivity (Tang et al., 2005, Tabibzadeh et 179 
al., 2000). As aforementioned, mature decidual cells are exquisitely responsive to embryo 180 
signals, especially trypsin-like proteases, and engage in active rejection by triggering 181 
menstruation-like shedding mediated by a decidual stress response (Brosens et al., 2014a). 182 
Taken together, these observations illustrate how the decidualization pathway contributes to 183 
the functional transition of the endometrium from a non-receptive (early-secretory phase) to a 184 
receptive (mid-secretory phase) and then a selective (late-secretory phase) state.  185 
 186 
The hallmark of the endometrium in recurrent miscarriage is a disordered and prolonged pro-187 
inflammatory decidual response. This excessive inflammatory response in turn prolongs the 188 
‘window of receptivity’, promotes out-of-phase implantation, and disables embryo selection 189 
(Salker et al., 2010, Salker et al., 2011, Salker et al., 2012, Lucas et al., 2016). Consequently, 190 
poor quality embryos are not disposed of in a timely manner and high-quality embryos 191 
implant in an unsupportive environment. Both scenarios lead to clinical miscarriage.  192 
 193 
‘Memory’ of endometrial stromal cells 194 
 195 
A truly prodigious finding, reported first 10 years ago, is that human endometrial stromal 196 
cells from individual patients closely phenocopy the decidual response in vivo upon 197 
differentiation in culture (Klemmt et al., 2006). Aberrant decidualization in culture has not 198 
only been reported for recurrent miscarriage patients (Francis et al., 2006, Salker et al., 2010) 199 
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but also for endometriosis (Klemmt et al., 2006, Aghajanova et al., 2011, Ahn et al., 2016) 200 
and polycystic ovary syndrome (Piltonen et al., 2015, Piltonen et al., 2013). However, while 201 
progesterone resistance, defined by the refractoriness of cultured human endometrial stromal 202 
cells to deciduogenic cues (Barragan et al., 2016), characterizes endometriosis patients; an 203 
excessive and prolonged inflammatory decidual response is typically associated with 204 
recurrent miscarriage (Salker et al., 2012).  205 
 206 
We hypothesized that an epigenetic mechanism may underlie this pathological ‘memory’ of 207 
endometrial stromal cells associated with recurrent miscarriage. Consequently, we sequenced 208 
immunoprecipitated methylated DNA (MeDIP-seq) to compare the global cytosine 209 
methylation profiles in primary cultures established from mid-luteal biopsies from recurrent 210 
miscarriage patients and control subjects (Lucas et al., 2016).  Disappointingly, the 211 
methylation signature at CG dinucleotides, the most common context of DNA methylation, 212 
was largely similar between the clinical groups, although there were notable differences in 213 
genes associated with decidualization and implantation processes, including the progesterone 214 
receptor co-activator high-mobility group box 2 (HMGB2) (Boonyaratanakornkit et al., 215 
1998). 216 
 217 
Some MeDIP-seq analysis pipelines utilize protocols based on the assumption that 218 
methylation is confined to CpG dinucleotides. When we re-analyzed the sequencing data 219 
using an unrestricted approach, a striking signature became apparent in endometrial stromal 220 
cells isolated from recurrent miscarriage samples, characterized by hypomethylation of 2,741 221 
loci. These differentially methylated regions (DMRs) overwhelmingly mapped to CA-rich 222 
regions that were largely devoid of CpG dinucleotides.  Many DMRs not only clustered 223 
within 15 Mb of the telomeres but also contained several DNA motifs that were selectively 224 
hypomethylated in recurrent miscarriage patients (Lucas et al., 2016).  225 
 226 
Methylation at CpH (H=A, C, T) is an epigenetic hallmark of stem cells, embryos and 227 
gametes (Ramsahoye et al., 2000, Shirane et al., 2013). It is lost in most somatic tissues but 228 
can be re-established upon pluripotency reprogramming of somatic cells (Ziller et al., 2011). 229 
Hence, we reasoned that the global CpH hypomethylation signature in endometrial stromal 230 
cells from recurrent miscarriage patients could be accounted for by lack of eMSCs or 231 
stemness.  232 
 233 
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 234 
eMSCs in recurrent miscarriage 235 
 236 
The defining feature of the human sexual cycle, shared with few other mammals, is 237 
menstruation. This remarkable phenomenon is triggered by falling progesterone levels in 238 
species that exhibit cyclic decidualization of the endometrium independently of an implanting 239 
embryo. MSCs regulate the main phases of wound healing via modulation of inflammatory 240 
response, promotion of angiogenesis and stimulation of cell movement (reviewed by Wang et 241 
al., 2016, Wong et al., 2015); thus a role for these cells in endometrial regeneration following 242 
menstruation, miscarriage or parturition is obvious. Endometrial MSCs share the classic 243 
properties of bone marrow MSCs, including clonogenicity, multipotency, the ability to 244 
reconstitute endometrial stroma in vivo, and expression of surface markers that distinguish 245 
them from leukocytes, hematopoietic and endothelial cells (reviewed by Gargett et al., 2016).  246 
 247 
As described for other organs, eMSCs predominantly reside in the perivascular niche of both 248 
the basal and functional layer (Ulrich et al., 2014, Masuda et al., 2012).  Screening the 249 
endometrium with a panel of perivascular markers identified SUSD2 (W5C5) as a powerful 250 
marker for selection of clonogenic endometrial cells (Masuda et al., 2012). The 251 
SUSD2/W5C5-positive cell population isolated by magnetic activated cell sorting constitutes 252 
approximately 6-7% of endometrial stromal cells. The SUSD2/W5C5-positive cell fraction 253 
contains on average 2-4% clonogenic cells (Masuda et al., 2012, Murakami et al., 2013). 254 
However, clonogenic eMSCs can also be isolated from the SUSD2/W5C5-negative cell 255 
fraction, although the relative abundance is much lower (0.7%) (Murakami et al., 2013). A 256 
recent gene expression profiling study provided compelling evidence that clonogenic eMSCs 257 
residing in the perivascular niche are the lineage precursors of the more committed non-258 
perivascular eMSCs (Barragan et al., 2016).  259 
 260 
To explain the CpH hypomethylation signature in endometrial stromal cells of recurrent 261 
miscarriage patients, we systematically measured the total number of freshly isolated 262 
SUSD2/W5C5-positive cells, the abundance of clonogenic SUSD2/W5C5-positive eMSCs 263 
and the abundance of clonogenic SUSD2/W5C5-negative eMSCs in mid-luteal biopsies 264 
obtained from 31 recurrent miscarriage patients and 28 control subjects. The total number of 265 
SUSD2/W5C5-positive cells did not differ between the study and control group. However, 266 
recurrent miscarriage was associated with a 41% reduction in the abundance of clonogenic 267 
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SUSD2/W5C5-positive eMSCs, respectively. Strikingly, no clonogenic SUSD2/W5C5-268 
negative eMSCs were recovered from 13 out of 31 (42%) recurrent miscarriage samples 269 
compared to 3 out of 28 (11%) control samples (Lucas et al., 2016).  270 
 271 
Both the level of methylation and the abundance of clonogenic cells correlated inversely with 272 
the severity of the miscarriage phenotype, defined by the number of previous pregnancy 273 
losses. Furthermore, eMSC deficiency has profound ramifications downstream of the 274 
differentiation pathway by accumulating senescent cells in the endometrial stromal 275 
compartment. Cellular senescence is associated with distinct pro-inflammatory cytokines and 276 
chemokines, matrix metalloproteinases and growth factors, termed senescence-associated 277 
secretory phenotype (SASP) (Acosta et al., 2013). Importantly, induction of senescence in 278 
primary endometrial stromal cells triggered a blunted but prolonged inflammatory secretory 279 
response upon decidualization, akin to the secretory response of primary cultures from 280 
recurrent miscarriage patients and likely reflecting the contribution of SASP (Lucas et al., 281 
2016).  282 
 283 
Perspective 284 
 285 
The advances in endometrial stem cell biology have generated innovative tools to accurately 286 
quantify and characterize eMSC populations associated with reproductive failure. 287 
Importantly, these advances are also re-writing our understanding of the biology of 288 
endometrial stromal cells. Rather than being a homogenous population, endometrial stromal 289 
cells, in vivo and in vitro, consist of a community of cells, ranging from quiescent and active 290 
MSCs, transit amplifying cells, mature fibroblasts and senescent cells. The observation that 291 
relative MSC deficiency and heightened cellular senescence is associated with recurrent 292 
miscarriage exemplifies that the decidual response, or more precisely the transitional decidual 293 
pathway, is determined by the balance of subpopulations that make up the community of 294 
stromal cells (Figure 2). By default, the constituents of this community, and thus the nature of 295 
the decidual response, changes with increasing distance away of the perivascular niche. A 296 
recent study illustrated this spatial organisation in the endometrium by demonstrating that 297 
perivascular SUSD2/W5C5-positive cells mount a distinct decidual response that could 298 
account for preferential homing of invading trophoblast to the spiral arteries (Murakami et 299 
al., 2014).   300 
 301 
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What causes eMSC deficiency in the uterus is a pertinent but as yet unanswered question. 302 
The properties and potential of adult stem cells are determined by a combination of intrinsic 303 
characteristics and a tissue-specific microenvironment. High Notch activity is a common 304 
niche feature and essential for cell-fate specification and maintenance of stem cells in a 305 
poised quiescent state (Cheung and Rando, 2013, Bjornson et al., 2012). For example, 306 
silencing of Notch signaling in skeletal cells leads to stem cell depletion and gives rise to 307 
muscles that lack the ability to regenerate in response to injury (Bjornson et al., 2012). By 308 
analogy, it seems plausible that pathological cues arising from dysmetabolic conditions 309 
associated with adverse pregnancy outcome, such as obesity, interfere with Notch signaling 310 
in the endometrium, thus gradually depleting the tissue of quiescent stem cells and rendering 311 
it vulnerable to damage in pregnancy. In support of this conjecture, a previous study reported 312 
that body mass index negatively correlates with cloning efficiency of endometrial 313 
SUSD2/W5C5-positive and -negative eMSCs (Murakami et al., 2013). Age, on the other 314 
hand, has no or little impact on the abundance of eMSCs (Murakami et al., 2013, Ulrich et 315 
al., 2014).  316 
 317 
These observations lead to other pertinent questions. How does the endometrium maintain its 318 
MSC populations over 400 or so cycles of tissue breakdown and regeneration? And is 319 
expansion of the eMSC population required to accommodate pregnancy? A widely held 320 
assumption is that eMSCs residing in the basal layer, which is not shed during menstruation, 321 
maintain the regenerative capacity of the endometrium from menarche until the menopause 322 
and beyond. However, this seems unlikely as age does not seem to impact on the abundance 323 
of eMSCs. An alternative scenario is that influx of immune cells, and specifically uterine 324 
natural killer cells, during the luteal phase plays a key role in homeostatic balancing of the 325 
stromal subpopulations through selective clearance of senescent cells (Hoenicke and Zender, 326 
2012). This attractive but as yet unproven scenario would link aberrant immune cell function 327 
to subsequent pregnancy failure without having to invoke a host-versus-graft response to the 328 
invading placental semi-allograft. Finally, it is not beyond the realms of possibility that 329 
decidual or trophoblast cues lead to expansion of eMSC population, in parallel with the 330 
expansion of the vascular bed. If this is the case, it would explain how the endometrium could 331 
self-correct over time and enable recurrent miscarriage patients to achieve a successful 332 
pregnancy after consecutive previous failures.  333 
 334 
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In summary, the discovery that eMSC deficiency is linked to recurrent miscarriage has 335 
provided new insights into the mechanisms of aberrant decidualization, lack of embryo 336 
selection and pregnancy failure. At the same time new questions have arisen regarding the 337 
mechanisms that control the maintenance of eMSCs from cycle to cycle and from pregnancy 338 
to pregnancy. Screening for eMSC deficiency may identify women at risk of recurrent 339 
reproductive failure and, conversely, harnessing the mechanisms that control endometrial 340 
stem cell populations may lead to effective interventions that reduce the physical and 341 
emotional trauma caused by recurrent miscarriage.  342 
 343 
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Figure legends 
 
Figure 1. Embryo selection at implantation and recurrent miscarriage. Pre-implantation 
human embryos are remarkably diverse. Most human embryos are mosaic. Normal 
blastomeres are indicated in green whereas a different colour indicates a distinct aneuploidy. 
While embryonic mosaicism bestows adaptability onto the species through genetic diversity, 
it also increases the risk of prolonged maternal investment in a failing pregnancy. Several 
embryo-intrinsic and -extrinsic mechanisms operate in early pregnancy to limit this risk, 
including embryonic self-correction (1), biosensoring of embryo quality by decidualizing 
(purple) cells (2), corpus luteum rescue by placental fitness hormones such as hCG (3), and 
oxidative stress associated with the onset of placental perfusion at the end of the 1
st
 trimester 
of pregnancy, effectively stress-testing the placental-decidual interface (4). Lack of embryo 
selection at implantation inevitably increases the risk of clinical miscarriage. Conversely, as a 
pregnancy transits to the 2
nd
 trimester, selection pressure decreases and the risk of further 
miscarriage drops markedly. 
 
Figure 2. Endometrial stromal compartment: a ‘community’ affair.  The stromal 
compartment of the endometrium is a mixed community of cells of quiescent and active 
MSCs, transit-amplifying cells, mature fibroblasts and senescent cells. The composition of 
this community changes with increased distance from the perivascular niche. The effect of 
eMSC deficiency is amplified downstream of the perivascular niche. Failure of homeostatic 
balancing of the constituents of the stromal community accounts for aberrant decidualization 
associated with recurrent miscarriage.  
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